Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC).

Two independent studies reveal that disease progression is delayed by combining two targeted therapies with the traditional ...

Liver cells attempt to shut down as a defense mechanism against cancer, but this strategy is not particularly effective.

In a groundbreaking medical achievement in the UK, a 32-year-old woman from Manchester has undergone the country's first ...

Cholesterol-lowering medications, like ezetimibe, may cut liver cancer risk by 31%. Discover how this breakthrough could help ...

But the man’s condition worsened, progressing into cirrhosis and eventually hepatocellular carcinoma, also known as liver ...